1/ How about some research inspiration during these rough times? In this thread we'll present 7 impressive companies from Denmark that might be worth a closer look ππ©π°
2/ $CHEMM
Market cap $1.7b
5Y Avg. RoIC 53%
LTM EBIT margin 46%
ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment, with a client base across cell-based immunotherapy, cancer and stem cell research, and drug development/research.
Market cap $1.7b
5Y Avg. RoIC 53%
LTM EBIT margin 46%
ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment, with a client base across cell-based immunotherapy, cancer and stem cell research, and drug development/research.
3/ $CHR
Market cap $9.8b
5Y Avg. RoIC 12%
LTM EBIT margin 27%
Chr. Hansen is a uniquely positioned soon 150 year old global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.
Market cap $9.8b
5Y Avg. RoIC 12%
LTM EBIT margin 27%
Chr. Hansen is a uniquely positioned soon 150 year old global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.
4/ $COLO
Market cap $26.6b
5Y Avg. RoIC 55%
LTM EBIT margin 32%
Coloplast's global business includes ostomy care, continence care, wound & skin care, interventional urology and Voice & respiratory care, addressing very personal and private medical needs.
Market cap $26.6b
5Y Avg. RoIC 55%
LTM EBIT margin 32%
Coloplast's global business includes ostomy care, continence care, wound & skin care, interventional urology and Voice & respiratory care, addressing very personal and private medical needs.
5/ $NOVO
Market cap $248b
5Y Avg. RoIC 70%
LTM EBIT margin 42%
Novo Nordisk is one of the largest and oldest (~100 years) insulin producers in the world, and one of Europe's 10 largest companies by market cap. Novo also treats obesity and rare blood/endocrine diseases.
Market cap $248b
5Y Avg. RoIC 70%
LTM EBIT margin 42%
Novo Nordisk is one of the largest and oldest (~100 years) insulin producers in the world, and one of Europe's 10 largest companies by market cap. Novo also treats obesity and rare blood/endocrine diseases.
6/ $NZYM
Market cap $17.3b
5Y Avg. RoIC 20%
LTM EBIT margin 26%
Novozymes (a Novo Nordisk spin-off) has a unique dedication to enzymes and microbes, producing a wide range of industrial enzymes and microorganisms used in everything from textiles, detergents and food.
Market cap $17.3b
5Y Avg. RoIC 20%
LTM EBIT margin 26%
Novozymes (a Novo Nordisk spin-off) has a unique dedication to enzymes and microbes, producing a wide range of industrial enzymes and microorganisms used in everything from textiles, detergents and food.
7/ $RBREW
Market cap $3.9b
5Y Avg. RoIC 20%
LTM EBIT margin 19%
Royal Unibrew is a leading multi-beverage company with strong local brand portfolios in their main markets in the Nordic and Baltic regions, as well as Italy and France, with sales in >65 countries.
Market cap $3.9b
5Y Avg. RoIC 20%
LTM EBIT margin 19%
Royal Unibrew is a leading multi-beverage company with strong local brand portfolios in their main markets in the Nordic and Baltic regions, as well as Italy and France, with sales in >65 countries.
8/ $SIM
Market cap $2.7b
5Y Avg. RoIC 43%
LTM EBIT margin 27%
SimCorp (est. 1971) has worked closely with investment and asset managers to become the worldβs leading provider of integrated investment management solutions for central banks as well as fund managers.
Market cap $2.7b
5Y Avg. RoIC 43%
LTM EBIT margin 27%
SimCorp (est. 1971) has worked closely with investment and asset managers to become the worldβs leading provider of integrated investment management solutions for central banks as well as fund managers.
Loading suggestions...